Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04817839 · ClinicalTrials.gov registry record · NA
Optimal Duration of Post-Operative Activity Restriction After Midurethral Sling Procedures
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 206
- Enrollment target
NCT04817839: Completed NA study, sponsored by Yale University.
NCT04817839 is a NA study that has completed, run by Yale University. The registered enrollment target is 206 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04817839, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 206 participants
- Enrollment target
Study Summary
The purpose of this study is to compare postoperative outcomes and patient satisfaction between 3 and 6-week postoperative restrictions after a midurethral sling procedure.
Primary Outcome
UDI form calculator assesses life quality and symptom distress in women suffering from urinary incontinence. The range is 0 to 70, higher means worse, lowers means better (higher is more symptoms.
Interventions
- BEHAVIORAL 3-week post-operative activity restriction
- BEHAVIORAL 6-week post-operative activity restriction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2024-12-16 |
| Phase | NA |
What the finished NCT04817839 record still lists
NCT04817839 is an interventional study that assigns participants to a tested intervention. The registered 206 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 2 interventions - of which 3-week post-operative activity restriction is the first listed.
NCT04817839 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04817839 about?
NCT04817839 is a clinical study titled "Optimal Duration of Post-Operative Activity Restriction After Midurethral Sling Procedures". The purpose of this study is to compare postoperative outcomes and patient satisfaction between 3 and 6-week postoperative restrictions after a midurethral sling procedure.
What is the current status of trial NCT04817839?
This trial is currently completed. It is a NA study. The enrollment target is 206 participants. The study started on 2021-07-01. Estimated completion is 2024-12-16.
What interventions are being tested in trial NCT04817839?
The interventions under investigation include: 3-week post-operative activity restriction (BEHAVIORAL), 6-week post-operative activity restriction (BEHAVIORAL).
Who is sponsoring clinical trial NCT04817839?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04817839's enrollment target sits among peer trials
206 499th of 2000 higher than 1,502 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03373968 · 206 participants · Phase 2
Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study
- NCT03550391 · 206 participants · Phase 3
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
- NCT04757116 · 206 participants · NA
Post-Market Study to Assess iTind Safety in Comparison to UroLift
- NCT05675865 · 206 participants · NA
Cryoablation for Monomorphic Ventricular Tachycardia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI